Top compounds associated with response to ACTB


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC 0.004 0.9
mRNA tivozanib CTRPv2 pan-cancer AAC 0.049 0.2
mRNA tivozanib GDSC1000 pan-cancer AAC 0.025 0.5
mRNA tosedostat CTRPv2 pan-cancer AAC 0.003 0.9
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.012 0.7
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.011 0.8
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.0079 0.8
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.022 0.6
mRNA triptolide CTRPv2 pan-cancer AAC -0.066 0.07
mRNA tubastatin A GDSC1000 pan-cancer AAC -0.039 0.2
Download CSV